While both Retatrutide and tirzepatide (known commercially as Zepbound) are Eli Lilly products targeting GLP-1 receptors, Retatrutide's additional action on GCG might promote greater appetite reduction and weight loss
Hasnylmirigy-gyullads Tjkoztassa kezelorvost, ha korbban valamilyen hasnylmirigy-betegsge volt, vagy jelenleg ilyen betegsge van
Speaker's Bureau: Novo-Nordisk, AstraZeneca Honorarium (Speaker) Funding None References Once Weekly Dulaglutide and Major Cardiovascular EventsResults of the REWIND Trial (Researching CV Events with a Weekly INcretin in Diabetes)
However, its reliance on 12 physiological variablesincluding temperature, mean arterial pressure, heart rate, respiratory rate, oxygenation index, arterial pH, serum sodium, potassium, creatinine, hematocrit, white blood cell count, and Glasgow Coma Scale scorecan make it impractical for non-intensive care unit (ICU) settings
Cagrilintide Phase 2 monotherapy (Lau et al., Lancet 2021) reported about 10.8% weight loss at 26 weeks at 4.5 mg